- About Us
- Prospective Postdocs
- Current Postdoc Fellows
- Faculty & Administrators
- Career Resources
News from BioSpace.com
Updated: 2 years 20 weeks ago
It was the small square photo clipped to an applicant's resume that most influenced whether a woman would be hired. But there was a hidden catch: The pictures showed the same six women both before and after weight-loss surgery. The end result: The "employers" in the study rated these six women more poorly when their photos were taken when they were obese.
One of life's simple pleasures just got a little sweeter. After years of waffling research on coffee and health, even some fear that java might raise the risk of heart disease, a big study finds the opposite: Coffee drinkers are a little more likely to live longer. Regular or decaf doesn't matter.
With Fat: What's Good or Bad for the Heart, May be the Same for the Brain, Brigham and Women's Hospital Study
It has been known for years that eating too many foods containing "bad" fats, such as saturated fats or trans fats, isn't healthy for your heart. However, according to new research from Brigham and Women's Hospital (BWH), one "bad" fatsaturated fatwas found to be associated with worse overall cognitive function and memory in women over time. By contrast, a "good" fatmono-unsaturated fat was associated...
A new paper published online in The Lancet challenges the assumption that raising a person's HDL -- the so-called "good cholesterol" -- will necessarily lower the risk of a heart attack. The new research underscores the value of using genetic approaches to test biological hypotheses about human disease prior to developing specific drugs. A team led by researchers from the Broad Institute and Massachusetts...
Three strikes and youre out? In 2006, the FDA noticed that Acorda Therapeutics was having difficulty submitting serious and unexpected adverse even reports within 15 days of receiving such information as required by law. The same problem was observed during yet another inspection three years later. And when the FDA returned last summer, the agency found Acorda was still failing to report adverse events...